Stay updated on RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial
Sign up to get notified when there's something new on the RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial page.

Latest updates to the RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe web page has been updated from version 2.16.1 to version 2.16.2.SummaryDifference0.0%
- Check21 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference0.9%
- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.0%
- Check64 days agoChange DetectedThe page has undergone significant content changes, including the removal of detailed descriptions of clinical trials for HER2-positive breast cancer treatments and the addition of a new version identifier.SummaryDifference53%
- Check71 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check79 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
Stay in the know with updates to RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RC48-ADC in HER2+ Metastatic Breast Cancer Clinical Trial page.